Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Changes in the Expression of miR-34a and its Target Genes Following Spinal Cord Injury In Rats.
Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.
Ontogeny of Tissue-Resident Macrophages.
Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation.
Olfactory dysfunction as a marker of multiple sclerosis progression.
Phosphorylated TandeMBP: A unique protein substrate for protein phosphatase assay.
The N-MOmentum trial: Building momentum to advance trial methodology in a rare disease.
Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
Gait Profile Score in multiple sclerosis patients with low disability.
Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.
Interferons and inflammasomes: Cooperation and counterregulation in disease.
Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.
Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand.
Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?
In vitro and ex vivo models of multiple sclerosis.
[May neuroimaging findings of a child with multiple sclerosis surprise us? Clinical and radiological observation].
Design, synthesis and docking studies of novel 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents.
Non-human Immunodeficiency Virus-related Ocular Syphilis in a Korean Population: Clinical Manifestations and Treatment Outcomes.
Subcortical grey matter volumes predict subsequent walking function in early multiple sclerosis.
Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders.
Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study.
Mortality in Hungarian patients with multiple sclerosis between 1993 and 2013.
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus.
Effect of oscillating electrical field stimulation on motor function recovery and myelin regeneration after spinal cord injury in rats.
Pages
« first
‹ previous
…
768
769
770
771
772
773
774
775
776
…
next ›
last »